Socioeconomic burden of influenza in the Republic of Korea, 2007-2010

PloS One
Mina SuhChangsoo Kim


Although the socioeconomic burden of 2009 pandemic influenza A (H1N1) was considerable, no reliable estimates have been reported. Our aim was to compared medical costs and socioeconomic burden resulting from pandemic influenza A (H1N1) 2009 with that of previous seasonal influenza. We estimated the medical costs and socioeconomic burden of influenza from May 2007 to April 2010. We used representative national data sources(data from the Health Insurance Review Agency, the National Health Insurance Corporation, the Korea Centers for Disease Control and Prevention, and the Korean National Statistics Office) including medical utilization, prescription of antivirals, and vaccination. Uncertainty of data was explored through sensitivity analysis using Monte Carlo simulation. Compared with the seasonal influenza, total medical costs (US$291.7 million) associated with pandemic (H1N1) 2009 increased more than 37-fold. Compared with the 2007-2008 season, outpatient diagnostic costs (US$135.3 million) were 773 times higher in the 2009-2010 season, and the mean diagnostic cost per outpatient visit was 58.8 times higher. Total socioeconomic burden of pandemic (H1N1) 2009 was estimated at US$1581.3 million (10%-90%: US$1436.0-1808.3 million)...Continue Reading


Oct 15, 2008·PharmacoEconomics·Martin Keech, Paul Beardsworth
Jan 31, 2009·International Journal of Oral and Maxillofacial Surgery·Y KimuraK Ono
May 9, 2009·The New England Journal of Medicine·Fatimah S DawoodTimothy M Uyeki
May 21, 2009·Influenza and Other Respiratory Viruses·James M Simmerman, Timothy M Uyeki
Nov 4, 2009·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Choong Wook LeeWon Young Kim
Apr 13, 2010·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Dong Han LeeJong Koo Lee
Apr 15, 2010·Social Work in Public Health·Kyo-Seong Kim, Young-Jae Lee
May 7, 2010·The New England Journal of Medicine·Edgar BautistaKarl G Nicholson
Jul 2, 2010·Journal of Korean Medical Science·Joon Hyung KimJong-Koo Lee
Jul 14, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M E FalagasP I Rafailidis
Mar 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sundar S ShresthaMartin I Meltzer
Apr 6, 2011·Australian and New Zealand Journal of Public Health·Vittal Mogasale, Jan Barendregt
Apr 22, 2011·American Journal of Obstetrics and Gynecology·Andreea A CreangaMargaret A Honein
Aug 2, 2011·Emerging Infectious Diseases·Nancy Val y Val P MotaAnna S Levin
Aug 27, 2011·American Journal of Infection Control·Yeon-Kyeng LeeJong-Koo Lee
Apr 19, 2012·Bulletin of the World Health Organization·Nusrat HomairaEduardo Azziz-Baumgartner

❮ Previous
Next ❯


Apr 4, 2015·Expert Review of Anti-infective Therapy·Young June ChoeEun Hwa Choi
Nov 28, 2014·International Journal of Environmental Research and Public Health·Hye Jung Yang, Sung-Il Cho
Jul 23, 2015·Ageing Research Reviews·Ramar Perumal Samy, Lina H K Lim
Apr 12, 2016·Tuberculosis and Respiratory Diseases·Jae Yeol Kim
Mar 10, 2017·PloS One·Won Suk ChoiWoo Joo Kim
Aug 11, 2015·Expert Review of Anti-infective Therapy·Joon Young SongWoo Joo Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.


Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.